<DOC>
	<DOCNO>NCT01173991</DOCNO>
	<brief_summary>The investigator postulate carbohydrate ( CHO ) count adult patient type 1 diabetes mellitus ( T1DM ) treat continuous subcutaneous insulin infusion ( CSII ) may improve glycemic control , glycemic variability quality life .</brief_summary>
	<brief_title>Carbohydrate Counting Adults With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion</brief_title>
	<detailed_description>This study design randomize , control ( versus standard education ) , open , one-center trial . Patients group 1 taught carbohydrate count estimate insulin preprandial bolus , patient group 2 follow standard education . Primary outcome ( glycosylated hemoglobin , HbA1c ) secondary outcome ( fast glucose , glycemic variability , insulin requirement , body mass index ( BMI ) , waist circumference , quality life ) measure baseline , 3 , 6 month .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>type 1 diabetes mellitus age 1865 continuous subcutaneous insulin infusion least 3 month patient already trained carbohydrate count know hypothyroidism replacement therapy renal disease ( serum creatinine &gt; 1.4 mg/dl female &gt; 1.7 mg/dl male ) patient celiac disease pregnancy serious disease disability may interfere study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>carbohydrate counting</keyword>
	<keyword>continuous subcutaneous insulin infusion</keyword>
	<keyword>type 1 diabetes mellitus</keyword>
</DOC>